107.521 articles found

Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine

Lauterbach Thomas Dr., Schacht Dietrich Wilhelm, Wolff Hans-Michael Dr., Müller Walter Dr..

· 2001-05-08

Pharmaceutical agents for the treatment of parkinson's disease, ADHD and microadenomas

MCLEAN STAFFORD, ZORN STEVIN H, JACKSON ELISA R.

· 2001-05-03

Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease

STICE STEVEN L, CIBELLI JOSE, ROBL JAMES M.

· 2001-05-01

Use of medium chain triglycerides for the treatment and prevention of Parkinson's disease, Huntington' disease or Amyloid Lateral Sclerosis resulting from reduced neuronal metabolism

HENDERSON SAMUEL T.

· 2001-05-01

Occipital glucose metabolism in dementia with lewy bodies with and without Parkinsonism: a study using positron emission tomography.

Imamura T, Ishii K, Hirono N, Hashimoto M, Tanimukai S, Kazui H, Hanihara T, Sasaki M, Mori E.

Dement Geriatr Cogn Disord · 2001-05-01

DOI: 10.1159/000051257PMID: 11244212

Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease.

Papapetropoulos S, Paschalis C, Athanassiadou A, Papadimitriou A, Ellul J, Polymeropoulos MH, Papapetropoulos T.

J Neurol Neurosurg Psychiatry · 2001-05-01

DOI: 10.1136/jnnp.70.5.662PMID: 11309462

Parkinson's disease, pesticides and mitochondrial dysfunction.

Jenner P.

Trends Neurosci · 2001-05-01

DOI: 10.1016/s0166-2236(00)01789-6PMID: 11311359

Fighting Bax: towards a Parkinson's disease therapy.

Ploix C, Spier AD.

Trends Neurosci · 2001-05-01

DOI: 10.1016/s0166-2236(00)01837-3PMID: 11311364

Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease.

Rodríguez M, Barroso-Chinea P, Abdala P, Obeso J, González-Hernández T.

Exp Neurol · 2001-05-01

DOI: 10.1006/exnr.2000.7624PMID: 11312569

Identification of four novel polymorphisms in the calcitonin/alpha-CGRP (CALCA) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression.

Buervenich S, Xiang F, Sydow O, Jönsson EG, Sedvall GC, Anvret M, Olson L.

Hum Mutat · 2001-05-01

DOI: 10.1002/humu.1126PMID: 11317366

Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease.

Mössner R, Henneberg A, Schmitt A, Syagailo YV, Grässle M, Hennig T, Simantov R, Gerlach M, Riederer P, Lesch KP.

Mol Psychiatry · 2001-05-01

DOI: 10.1038/sj.mp.4000849PMID: 11326308

Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations.

Kawamata H, McLean PJ, Sharma N, Hyman BT.

J Neurochem · 2001-05-01

DOI: 10.1046/j.1471-4159.2001.00301.xPMID: 11331421